Hematuria as a marker of occult urinary tract cancer: Advice for high-value care from the American college of physicians

Annals of Internal Medicine

Volumn 164, Issue 7, 2016, Pages 488-497

  Nielsen, Matthew ^a   Qaseem, Amir ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b AMERICAN COLLEGE OF PHYSICIANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CYSTOSCOPY; ERYTHROCYTE; FALSE POSITIVE RESULT; GENERAL PRACTITIONER; HEMATURIA; HUMAN; INTERNIST; PATIENT REFERRAL; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; URINALYSIS; URINARY TRACT CANCER; URINE CYTOLOGY; UROLOGY; ADULT; ASYMPTOMATIC DISEASE; BLOOD; CLINICAL PRACTICE; ECONOMICS; HEALTH CARE COST; RISK FACTOR; UROLOGIC NEOPLASMS;

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER;

ADULT; ANTICOAGULANTS; ASYMPTOMATIC DISEASES; BIOMARKERS; CYSTOSCOPY; DIRECT SERVICE COSTS; HEMATURIA; HUMANS; PHYSICIANS, PRIMARY CARE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; REFERRAL AND CONSULTATION; RISK FACTORS; URINALYSIS; UROLOGIC NEOPLASMS;

EID: 84962667799     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-1496     Document Type: Article

References (76)

1. Mohr DN, Offord KP, Owen RA, Melton LJ 3rd. Asymptomatic microhematuria and urologic disease. A population-based study. JAMA. 1986;256: 224-9. [PMID: 3723707]
2. Woolhandler S, Pels RJ, Bor DH, Himmelstein DU, Lawrence RS. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA. 1989;262: 1214-9. [PMID: 2668582]
3. Moyer VA; U.S. Preventive Services Task Force. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2011;155: 246-51. [PMID: 21844550] doi: 10.7326/0003-4819-155-4-201108160-00008
4. Logsetty S. Screening for bladder cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa, Ontario, Canada: Health Canada; 1994: 826-36.
5. Chacko KM, Feinberg LE. Laboratory screening at preventive health exams: Trend of testing, 1978-2004. Am J Prev Med. 2007;32: 59-62. [PMID: 17218191]
6. Prochazka AV, Lundahl K, Pearson W, Oboler SK, Anderson RJ. Support of evidence-based guidelines for the annual physical examination: A survey of primary care providers. Arch Intern Med. 2005; 165: 1347-52. [PMID: 15983282]
7. Edwards TJ, Dickinson AJ, Natale S, Gosling J, McGrath JS. A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006;97: 301-5. [PMID: 16430634]
8. Loo RK, Lieberman SF, Slezak JM, Landa HM, Mariani AJ, Nicolaisen G, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013;88: 129-38. [PMID: 23312369] doi: 10.1016/j.mayocp.2012.10.004
9. Mariani AJ, Mariani MC, Macchioni C, Stams UK, Hariharan A, Moriera A. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989;141: 350-5. [PMID: 2492350]
10. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000;163: 524-7. [PMID: 10647670]
11. Jung H, Gleason JM, Loo RK, Patel HS, Slezak JM, Jacobsen SJ. Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J Urol. 2011;185: 1698-703. [PMID: 21419446] doi: 10.1016/j.juro.2010.12.093
12. Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, et al; American Urological Association. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188: 2473-81. [PMID: 23098784] doi: 10.1016/j.juro.2012.09.078
13. Mishriki SF, Nabi G, Cohen NP. Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: Prospective study with 13 years' follow-up. Urology. 2008;71: 13-6. [PMID: 18242356] doi: 10.1016/j.urology.2007.08.031
14. Britton JP, Dowell AC, Whelan P. Dipstick haematuria and bladder cancer in men over 60: Results of a community study. BMJ. 1989; 299: 1010-2. [PMID: 2511941]
15. Britton JP, Dowell AC, Whelan P, Harris CM. A community study of bladder cancer screening by the detection of occult urinary bleeding. J Urol. 1992;148: 788-90. [PMID: 1512826]
16. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy- part I: Definition, detection, prevalence, and etiology. Urology. 2001; 57: 599-603. [PMID: 11306356]
17. Messing EM, Young TB, Hunt VB, Wehbie JM, Rust P. Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age. Cancer. 1989;64: 2361-7. [PMID: 2804928]
18. Messing EM, Young TB, Hunt VB, Roecker EB, Vaillancourt AM, Hisgen WJ, et al. Home screening for hematuria: Results of a multiclinic study. J Urol. 1992;148: 289-92. [PMID: 1635120]
19. Bassett JC, Alvarez J, Koyama T, Resnick M, You C, Ni S, et al. Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries. J Gen Intern Med. 2015;30: 440-7. [PMID: 25451992] doi: 10.1007/s11606-014-3116-2
20. Nieder AM, Lotan Y, Nuss GR, Langston JP, Vyas S, Manoharan M, et al. Are patients with hematuria appropriately referred to urology? A multi-institutional questionnaire based survey. Urol Oncol. 2010;28: 500-3. [PMID: 19097811] doi: 10.1016/j.urolonc.2008.10.018
21. Buteau A, Seideman CA, Svatek RS, Youssef RF, Chakrabarti G, Reed G, et al. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol. 2014;32: 128-34. [PMID: 23153858] doi: 10.1016/j.urolonc.2012.07.001
22. Rao PK, Gao T, Pohl M, Jones JS. Dipstick pseudohematuria: Unnecessary consultation and evaluation. J Urol. 2010;183: 560-4. [PMID: 20018314] doi: 10.1016/j.juro.2009.10.049
23. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: A nationwide claims-based investigation. Cancer. 2014; 120: 555-61. [PMID: 24496869] doi: 10.1002/cncr.28416
24. Elias K, Svatek RS, Gupta S, Ho R, Lotan Y. High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer. 2010;116: 2954-9. [PMID: 20564400] doi: 10.1002/cncr.25048
25. Friedlander DF, Resnick MJ, You C, Bassett J, Yarlagadda V, Penson DF, et al. Variation in the intensity of hematuria evaluation: A target for primary care quality improvement. Am J Med. 2014;127: 633-640.e11. [PMID: 24486290] doi: 10.1016/j.amjmed.2014.01.010
26. Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW, et al. Gender disparities in hematuria evaluation and bladder cancer diagnosis: A population based analysis. J Urol. 2014;192: 1072-7. [PMID: 24835058] doi: 10.1016/j.juro.2014.04.101
27. Johnson EK, Daignault S, Zhang Y, Lee CT. Patterns of hematuria referral to urologists: Does a gender disparity exist? Urology. 2008; 72: 498-502. [PMID: 18619657] doi: 10.1016/j.urology.2008.01.086
28. Hiatt RA, Ordoñez JD. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. Cancer Epidemiol Biomarkers Prev. 1994; 3: 439-43. [PMID: 7848421]
29. Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, et al. Diagnosis, Evaluation and Follow-up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline. Linthicum, MD: American Urological Association; 2012. Accessed at www.auanet.org/common/pdf/education/clinical-guidance/Asymptomatic-Micro hematuria.pdf on 30 September 2014.
30. Wollin T, Laroche B, Psooy K. Canadian guidelines for the management of asymptomatic microscopic hematuria in adults. Can Urol Assoc J. 2009;3: 77-80. [PMID: 19293985]
31. van der Molen AJ, Hovius MC. Hematuria: A problem-based imaging algorithm illustrating the recent Dutch guidelines on hematuria. AJR Am J Roentgenol. 2012;198: 1256-65. [PMID: 22623537] doi: 10.2214/AJR.11.8255
32. Fawcett D, Kelly J, Goldberg L, Anderson J, Feehally J, MacTier R, on behalf of the Renal Association and British Association of Urological Surgeons. Joint Consensus Statement on the Initial Assessment of Haematuria. 2008. Accessed at www.renal.org/docs/default -source/what-we-do/RA-BAUS-Haematuria-Consensus-Guidelines.pdf?sfvrsn=0 on 21 December 2015.
33. American Urological Association. Choosing Wisely: Ten Things Physicians and Patients Should Question. Linthicum, MD: American Urological Association; 2015. Accessed at www.choosingwisely.org/societies/american-urological-association on 1 September 2015.
34. Messing EM, Young TB, Hunt VB, Emoto SE, Wehbie JM. The significance of asymptomatic microhematuria in men 50 or more years old: Findings of a home screening study using urinary dipsticks. J Urol. 1987;137: 919-22. [PMID: 2437335]
35. Messing EM, Young TB, Hunt VB, Newton MA, Bram LL, Vaillancourt A, et al. Hematuria home screening: Repeat testing results. J Urol. 1995;154: 57-61. [PMID: 7776456]
36. Cumberbatch MG, Cox A, Teare D, Catto JW. Contemporary occupational carcinogen exposure and bladder cancer: A systematic review and meta-analysis. JAMA Oncol. 2015: 1-9. [PMID: 26448641] doi: 10.1001/jamaoncol.2015.3209
37. National Institute for Health and Care Excellence. Suspected cancer: Recognition and referral. NICE guideline. London: National Institute for Health and Care Excellence; 2015. Accessed at www.nice.org.uk/guidance/ng12/resources/suspected-cancer-recognition -and-referral-1837268071621 on 15 August 2015.
38. Shen L, Raman SS, Beland MD, Moreno CC, Goldfarb S, Harvin HJ, et al. ACR Appropriateness Criteria: Hematuria. 2014. Accessed at www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/Hematuria.pdf on 1 October 2014.
39. Culclasure TF, Bray VJ, Hasbargen JA. The significance of hematuria in the anticoagulated patient. Arch Intern Med. 1994;154: 649-52. [PMID: 8129498]
40. Van Savage JG, Fried FA. Anticoagulant associated hematuria: A prospective study. J Urol. 1995;153: 1594-6. [PMID: 7536272]
41. Hurlen M, Eikvar L, Seljeflot I, Arnesen H. Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis. Thromb Res. 2006;118: 433-8. [PMID: 16139331]
42. Chou R, Gore JL, Buckley D, Fu R, Gustafson K, Griffin JC, et al. Urinary biomarkers for diagnosis of bladder cancer. A systematic review and meta-analysis. Ann Intern Med. 2015;163: 922-31. doi: 10.7326/M15-0997
43. RanéA, Cahill D, Saleemi A, Montgomery B, Palfrey E. The issue of prophylactic antibiotics prior to flexible cystoscopy. Eur Urol. 2001;39: 212-4. [PMID: 11223682]
44. Johnson MI, Merrilees D, Robson WA, Lennon T, Masters J, Orr KE, et al. Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. BJU Int. 2007;100: 826-9. [PMID: 17822463]
45. Herr HW. The risk of urinary tract infection after flexible cystoscopy in patients with bladder tumor who did not receive prophylactic antibiotics. J Urol. 2015;193: 548-51. [PMID: 25046618] doi: 10.1016/j.juro.2014.07.015
46. Wilson L, Ryan J, Thelning C, Masters J, Tuckey J. Is antibiotic prophylaxis required for flexible cystoscopy? A truncated randomized double-blind controlled trial. J Endourol. 2005;19: 1006-8. [PMID: 16253070]
47. Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy; a literature review. J Nephropathol. 2014;3: 51-6. [PMID: 24772397] doi: 10.12860/jnp.2014.12
48. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007;357: 2277-84. [PMID: 18046031]
49. Board on Radiation Effects Research, Division on Earth and Life Studies. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: National Academies Pr; 2006.
50. Vrtiska TJ, Hartman RP, Kofler JM, Bruesewitz MR, King BF, Mc- Collough CH. Spatial resolution and radiation dose of a 64-MDCT scanner compared with published CT urography protocols. AJR Am J Roentgenol. 2009;192: 941-8. [PMID: 19304698] doi: 10.2214/AJR.07.2679
51. Tsili AC, Efremidis SC, Kalef-Ezra J, Giannakis D, Alamanos Y, Sofikitis N, et al. Multi-detector row CT urography on a 16-row CT scanner in the evaluation of urothelial tumors. Eur Radiol. 2007;17: 1046-54. [PMID: 17021709]
52. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: A catalog. Radiology. 2008;248: 254-63. [PMID: 18566177] doi: 10.1148/radiol.2481071451
53. Smith-Bindman R, Miglioretti DL, Larson EB. Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood). 2008;27: 1491-502. [PMID: 18997204] doi: 10.1377/hlthaff.27.6.1491
54. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169: 2078-86. [PMID: 20008690] doi: 10.1001/archinternmed.2009.427
55. Shuryak I, Sachs RK, Brenner DJ. Cancer risks after radiation exposure in middle age. J Natl Cancer Inst. 2010;102: 1628-36. [PMID: 20975037] doi: 10.1093/jnci/djq346
56. McBride JF, Wardrop RM 3rd, Paxton BE, Mandrekar J, Fletcher JG. Effect on examination ordering by physician attitude, common knowledge, and practice behavior regarding CT radiation exposure. Clin Imaging. 2012;36: 455-461.e1. [PMID: 22920345] doi: 10.1016/j.clinimag.2012.01.001
57. Loo R, Whittaker J, Rabrenivich V. National practice recommendations for hematuria: How to evaluate in the absence of strong evidence? Perm J. 2009;13: 37-46. [PMID: 21373244]
58. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, et al. Managing incidental findings on abdominal CT: White paper of the ACR incidental findings committee. J AmColl Radiol. 2010;7: 754-73. [PMID: 20889105] doi: 10.1016/j.jacr.2010.06.013
59. Liu W, MorteléKJ, Silverman SG. Incidental extraurinary findings at MDCT urography in patients with hematuria: Prevalence and impact on imaging costs. AJR Am J Roentgenol. 2005;185: 1051-6. [PMID: 16177432]
60. Berland LL. Incidental extracolonic findings on CT colonography: The impending deluge and its implications. J Am Coll Radiol. 2009; 6: 14-20. [PMID: 19111266] doi: 10.1016/j.jacr.2008.06.018
61. Centers for Medicare & Medicaid Services. Clinical laboratory fee schedule. Baltimore: Centers for Medicare & Medicaid Services; 2015. Accessed at www.cms.gov/Medicare/Medicare-Fee-for -Service-Payment/ClinicalLabFeeSched/clinlab.html on 3 September 2015.
62. Centers for Medicare & Medicaid Services. Physician Fee Schedule Search. Baltimore: Centers for Medicare & Medicaid Services; 2015. Accessed at www.cms.gov/apps/physician-fee-schedule/search/search-results.aspx?Y=0&T=0&HT=0&CT=0&H1=77263&M=5 on 3 September 2015.
63. Centers for Medicare & Medicaid Services. Hospital Outpatient PPS. Baltimore: Centers for Medicare & Medicaid Services; 2015. Accessed at www.cms.gov/Medicare/Medicare-Fee-for-Service -Payment/HospitalOutpatientPPS/Hospital-Outpatient-Regulations -and-Notices-Items/CMS-1613-CN.html on 3 September 2015.
64. Kaiser Family Foundation; Health Research & Educational Trust. Employer Health Benefits: 2014 Annual Survey. 2014. Accessed at http://files.kff.org/attachment/2014-employer-health-benefits-survey -full-report on 31 January 2015.
65. HealthPocket. Bronze Plan - Affordable Care Act (Obamacare). Accessed at www.healthpocket.com/individual-health-insurance/bronze-health-plans#.VIXeMv8tDGg on 31 January 2015.
66. Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med. 2003;348: 2330-8. [PMID: 12788998]
67. Grossfeld GD, Litwin MS, Wolf JS Jr, Hricak H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy- part II: Patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001;57: 604-10. [PMID: 11306357]
68. Corwin HL, Silverstein MD. Microscopic hematuria. Clin Lab Med. 1988;8: 601-10. [PMID: 3139354]
69. Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA, Kim SP, et al. Delays in diagnosis and bladder cancer mortality. Cancer. 2010;116: 5235-42. [PMID: 20665490] doi: 10.1002/cncr.25310
70. Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA. Gender differences in stage distribution of bladder cancer. Urology. 2000;55: 368-71. [PMID: 10699612]
71. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in U.S. adults: A cost-effectiveness analysis. JAMA. 2003;290: 3101-14. [PMID: 14679273]
72. Friderichsen B, Maunsbach M. Glycosuric tests should not be employed in population screenings for NIDDM. J Public Health Med. 1997;19: 55-60. [PMID: 9138218]
73. Rodgers M, Nixon J, Hempel S, Aho T, Kelly J, Neal D, et al. Diagnostic tests and algorithms used in the investigation of haematuria: Systematic reviews and economic evaluation. Health Technol Assess. 2006;10: Iii-iv, xi-259. [PMID: 16729917]
74. Ubel PA. Medical facts versus value judgments-toward preference-sensitive guidelines. N Engl J Med. 2015;372: 2475-7. [PMID: 26107051] doi: 10.1056/NEJMp1504245
75. Hole B, Whittlestone T, Tomson C. Investigating asymptomatic invisible haematuria. BMJ. 2014;349: G6768. [PMID: 25404006] doi: 10.1136/bmj.g6768
76. Qaseem A, Alguire P, Dallas P, Feinberg LE, Fitzgerald FT, Horwitch C, et al. Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med. 2012;156: 147-9. [PMID: 22250146] doi: 10.7326/0003-4819-156-2-201201170 -00011